These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6423768)

  • 1. Control mechanisms governing the infectivity of Chlamydia trachomatis for HeLa cells: the role of calmodulin.
    Murray A; Ward ME
    J Gen Microbiol; 1984 Jan; 130(1):193-201. PubMed ID: 6423768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control mechanisms governing the infectivity of Chlamydia trachomatis for HeLa cells: mechanisms of endocytosis.
    Ward ME; Murray A
    J Gen Microbiol; 1984 Jul; 130(7):1765-80. PubMed ID: 6470672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control mechanisms governing the infectivity of Chlamydia trachomatis for hela cells: modulation by cyclic nucleotides, prostaglandins and calcium.
    Ward ME; Salari H
    J Gen Microbiol; 1982 Mar; 128(3):639-50. PubMed ID: 6281367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of ions on the adhesion and internalization of Chlamydia trachomatis by HeLa cells.
    Sneddon JM; Wenman WM
    Can J Microbiol; 1985 Apr; 31(4):371-4. PubMed ID: 4005718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Damage/Danger Associated Molecular Patterns (DAMPs) Modulate Chlamydia pecorum and C. trachomatis Serovar E Inclusion Development In Vitro.
    Leonard CA; Schoborg RV; Borel N
    PLoS One; 2015; 10(8):e0134943. PubMed ID: 26248286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic energy dependency of
    Liang P; Rosas-Lemus M; Patel D; Fang X; Tuz K; Juárez O
    J Biol Chem; 2018 Jan; 293(2):510-522. PubMed ID: 29123027
    [No Abstract]   [Full Text] [Related]  

  • 7. Maraviroc, celastrol and azelastine alter
    Kuratli J; Leonard CA; Nufer L; Marti H; Schoborg R; Borel N
    J Med Microbiol; 2020 Dec; 69(12):1351-1366. PubMed ID: 33180014
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhancement of adherence and growth of Chlamydia trachomatis by estrogen treatment of HeLa cells.
    Bose SK; Goswami PC
    Infect Immun; 1986 Sep; 53(3):646-50. PubMed ID: 3744558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An early event in the herpes simplex virus type-2 replication cycle is sufficient to induce Chlamydia trachomatis persistence.
    Deka S; Vanover J; Sun J; Kintner J; Whittimore J; Schoborg RV
    Cell Microbiol; 2007 Mar; 9(3):725-37. PubMed ID: 17140408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937).
    Mpiga P; Ravaoarinoro M
    Int J Antimicrob Agents; 2006 Apr; 27(4):316-24. PubMed ID: 16527461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlamydia trachomatis interrupts an exocytic pathway to acquire endogenously synthesized sphingomyelin in transit from the Golgi apparatus to the plasma membrane.
    Hackstadt T; Rockey DD; Heinzen RA; Scidmore MA
    EMBO J; 1996 Mar; 15(5):964-77. PubMed ID: 8605892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polypeptide composition of Chlamydia trachomatis.
    Salari SH; Ward ME
    J Gen Microbiol; 1981 Apr; 123(2):197-207. PubMed ID: 7320696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vesicular interactions of the Chlamydia trachomatis inclusion are determined by chlamydial early protein synthesis rather than route of entry.
    Scidmore MA; Rockey DD; Fischer ER; Heinzen RA; Hackstadt T
    Infect Immun; 1996 Dec; 64(12):5366-72. PubMed ID: 8945589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surfactant protein D is present in the human female reproductive tract and inhibits Chlamydia trachomatis infection.
    Oberley RE; Goss KL; Ault KA; Crouch EC; Snyder JM
    Mol Hum Reprod; 2004 Dec; 10(12):861-70. PubMed ID: 15489244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 2-pyridone-amide inhibitor targets the glucose metabolism pathway of Chlamydia trachomatis.
    Engström P; Krishnan KS; Ngyuen BD; Chorell E; Normark J; Silver J; Bastidas RJ; Welch MD; Hultgren SJ; Wolf-Watz H; Valdivia RH; Almqvist F; Bergström S
    mBio; 2014 Dec; 6(1):e02304-14. PubMed ID: 25550323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hypothetical protein CT813 is localized in the Chlamydia trachomatis inclusion membrane and is immunogenic in women urogenitally infected with C. trachomatis.
    Chen C; Chen D; Sharma J; Cheng W; Zhong Y; Liu K; Jensen J; Shain R; Arulanandam B; Zhong G
    Infect Immun; 2006 Aug; 74(8):4826-40. PubMed ID: 16861671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host cell phospholipids are trafficked to and then modified by Chlamydia trachomatis.
    Wylie JL; Hatch GM; McClarty G
    J Bacteriol; 1997 Dec; 179(23):7233-42. PubMed ID: 9393685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of calmodulin in the responses to adrenocorticotropin of plasma membranes from adrenal cells.
    Papadopoulos V; Widmaier EP; Hall PF
    Endocrinology; 1990 May; 126(5):2465-73. PubMed ID: 2158426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Ureaplasma parvum co-incubation on Chlamydia trachomatis maturation in human epithelial HeLa cells treated with interferon-γ.
    Yamazaki T; Matsuo J; Nakamura S; Oguri S; Yamaguchi H
    J Infect Chemother; 2014 Aug; 20(8):460-4. PubMed ID: 24855914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of persistent infection by Chlamydia trachomatis serovar K in TPA-differentiated U937 cells and the role of IFN-gamma.
    Nettelnbreker E; Zeidler H; Bartels H; Dreses-Werringloer U; Däubener W; Holtmann H; Köhler L
    J Med Microbiol; 1998 Feb; 47(2):141-9. PubMed ID: 9879957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.